Autism Spectrum Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
For children with autism (Case Group):
Who might be able to join this trial:
- Children who have been diagnosed with autism spectrum disorder (ASD) based on standard diagnostic guidelines and confirmed with a specific assessment tool called ADOS-2
- Children between 2 and 17 years old
- Parents or caregivers who understand what the study involves and agree for their child to take part
Who may not be able to join:
- Children diagnosed with certain genetic conditions, including Rett Syndrome, Fragile X Syndrome, Angelman Syndrome, Prader-Willi Syndrome, tuberous sclerosis, or other conditions caused by known genetic or inherited metabolic disorders
- Children who have had a brain injury or have a significant long-term or congenital (present from birth) health condition
- Children who were born before 37 weeks of pregnancy or who weighed less than 2,500g (about 5.5 lbs) at birth
- Children who are unable to have a brain MRI scan
For healthy children (Control Group):
Who might be able to join this trial:
- Healthy children between 2 and 17 years old
- Children with no family history of autism or other neurodevelopmental or mental health conditions
- Parents or caregivers who understand what the study involves and agree for their child to take part
Who may not be able to join:
- Children who have had a brain injury or have a significant long-term or congenital (present from birth) health condition
- Children who were born before 37 weeks of pregnancy or who weighed less than 2,500g (about 5.5 lbs) at birth
- Children who are unable to have a brain MRI scan
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiu Xu, Children's Hospital of Fudan University
Phone: 13701989113
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
clinical diagnosis; Latencies in event related potentials(ERPs); Amplitudes in ERPs; nuclear magnetic resonance imaging(MRI); Changes in the concentrations of Oxygenated Hemoglobin (HbO) and deoxygenated Hemoglobin (HbR) during interactions
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.